Vaccinating older adults against shingles in Canada is likely cost-effective, according to a study inCMAJ(Canadian Medical Association Journal), and the Shingrix vaccine appears to provide better protection than the Zostavax vaccine. Herpes zoster, or shingles, affects about 1 in every 3 adults, ca...
VACCINATION statusINFLATION Reduction Act of 2022This cross-sectional study uses data from retail pharmacies to examine shingles vaccine uptake among Medicare Part D beneficiaries following an IRA policy to eliminate cost sharing.Qato, Dima M.
Shingles vaccination is likely to be cost effective at age 65 or 70Dobson R.doi:10.1136/bmj.b944Roger DobsonBMJBmjDobson R. Shingles vaccination is likely to be cost effective at age 65 or 70. BMJ. 2009; 338 :b944.